Gary Nabel
Director/Board Member at SIGA TECHNOLOGIES, INC.
Net worth: 25 M $ as of 2024-03-30
Gary Nabel active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SIGA TECHNOLOGIES, INC. | Director/Board Member | 2021-06-14 | - |
| Independent Dir/Board Member | 2021-06-14 | - | |
| OPKO HEALTH, INC. | Director/Board Member | 2022-05-08 | - |
| Corporate Officer/Principal | 2022-05-08 | - | |
| CANDEL THERAPEUTICS, INC. | Director/Board Member | 2022-08-07 | - |
| Independent Dir/Board Member | 2022-08-07 | - |
Career history of Gary Nabel
Former positions of Gary Nabel
| Companies | Position | Start | End |
|---|---|---|---|
Modex Therapeutics, Inc.
 Modex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of OPKO Health, Inc., ModeX Therapeutics, Inc. is a biotechnology research company focused on developing multi-specific immune therapies for cancer and infectious diseases. The private company is based in Natick, MA. The company was founded in 2020 by Elias A. Zerhouni, Gary J. Nabel, Alexis A. Borisy. ModeX Therapeutics was acquired by OPKO Health, Inc. on May 09, 2022 for $300 million. | Chief Executive Officer | 2020-10-31 | 2022-04-30 |
| Founder | 2020-10-31 | 2022-04-30 | |
| President | 2020-10-31 | 2022-04-30 | |
| SANOFI | Chief Tech/Sci/R&D Officer | 2012-11-15 | 2020-10-31 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 1998-12-31 | 2011-12-31 |
Keystone Symposia
 Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Keystone Symposia operates as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops. The company was founded by C. Fred Fox in 1972 and is headquartered in Silverthorne, CO. | Chairman | - | - |
Training of Gary Nabel
| Harvard University | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Statistics
International
| United States | 9 |
| France | 2 |
Operational
| Director/Board Member | 3 |
| Independent Dir/Board Member | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| SIGA TECHNOLOGIES, INC. | Health Technology |
| SANOFI | Health Technology |
| OPKO HEALTH, INC. | Health Services |
| CANDEL THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Keystone Symposia
Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Keystone Symposia operates as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops. The company was founded by C. Fred Fox in 1972 and is headquartered in Silverthorne, CO. | Commercial Services |
Modex Therapeutics, Inc.
Modex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of OPKO Health, Inc., ModeX Therapeutics, Inc. is a biotechnology research company focused on developing multi-specific immune therapies for cancer and infectious diseases. The private company is based in Natick, MA. The company was founded in 2020 by Elias A. Zerhouni, Gary J. Nabel, Alexis A. Borisy. ModeX Therapeutics was acquired by OPKO Health, Inc. on May 09, 2022 for $300 million. | Commercial Services |
- Stock Market
- Insiders
- Gary Nabel
- Experience
